File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function

TitleAlternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function
Authors
KeywordsLupus
Dendritic cells
Issue Date2015
PublisherPacini Editore SpA. The Journal's web site is located at http://www.clinexprheumatol.org
Citation
11th International Congress on Systemic Lupus Erythematosus, Vienna, Austria, 2-6 September 2015. In Clinical and Experimental Rheumatology, 2015, v. 33 n. 3, Suppl 90, p. S-21, abstract no. P3.14 How to Cite?
AbstractBackground:Tolerogenic dendritic cells (DCs) are increasingly explored as cell-based therapy in murine model of autoimmune diseases and may have potential therapeutic implications in the treatment of systemic lupus erythematosus (SLE) that is characterised by dysregulated innate and adaptive immune responses. Objectives: In this study, we generated alternatively activated DCs (aaDCs) from SLE patients and healthy subjects and examined their immunoregulatory properties in vitro. Methods: aaDCs were generated by treating monocyte-derived DCs by combination of 1,25 dihydroxyvitamin D(3) (vitD3) and dexamethasone followed by lipopolysaccharide-induced maturation Results: Lupus aaDCs were found to acquire semi-mature phenotype that remained resistant to immunostimulatory effect of sCD40L, CpG-DNA and SLE serum. These cells produced low level of IL-12 but high level of IL-10. They had attenuated allostimulatory effect on T cell activation and proliferation comparable to normal aaDCs and demonstrated differential immunomodulatory effects on naïve and memory T cells. These aaDCs were capable of inducing IL-10 producing regulatory T effectors from naïve T cells whereas they modulated cytokine profile with suppressed production of IFN-γ and IL-17 by co-cultured memory T cells with attenuated proliferation. The tolerogenicity of aaDCs was shown to be superior than those generated using vitD3 alone in lupus patients. aaDCs expressed lower level of RelB but apoptosis of DCs and IL12/IL-10 imbalance were not found to account for their tolerogenicity. Conclusions: Combination of vitD3 and dexamethasone represented a feasible method in the generation of tolerogenic DCs from SLE patients.
DescriptionSession: P03 (Auto-)immunity (misc.): Poster presentation
Persistent Identifierhttp://hdl.handle.net/10722/217518
ISSN
2015 Impact Factor: 2.495
2015 SCImago Journal Rankings: 0.953

 

DC FieldValueLanguage
dc.contributor.authorWu, H-
dc.contributor.authorLo, Y-
dc.contributor.authorLuk, TW-
dc.contributor.authorMok, TMY-
dc.date.accessioned2015-09-18T06:01:53Z-
dc.date.available2015-09-18T06:01:53Z-
dc.date.issued2015-
dc.identifier.citation11th International Congress on Systemic Lupus Erythematosus, Vienna, Austria, 2-6 September 2015. In Clinical and Experimental Rheumatology, 2015, v. 33 n. 3, Suppl 90, p. S-21, abstract no. P3.14-
dc.identifier.issn0392-856X-
dc.identifier.urihttp://hdl.handle.net/10722/217518-
dc.descriptionSession: P03 (Auto-)immunity (misc.): Poster presentation-
dc.description.abstractBackground:Tolerogenic dendritic cells (DCs) are increasingly explored as cell-based therapy in murine model of autoimmune diseases and may have potential therapeutic implications in the treatment of systemic lupus erythematosus (SLE) that is characterised by dysregulated innate and adaptive immune responses. Objectives: In this study, we generated alternatively activated DCs (aaDCs) from SLE patients and healthy subjects and examined their immunoregulatory properties in vitro. Methods: aaDCs were generated by treating monocyte-derived DCs by combination of 1,25 dihydroxyvitamin D(3) (vitD3) and dexamethasone followed by lipopolysaccharide-induced maturation Results: Lupus aaDCs were found to acquire semi-mature phenotype that remained resistant to immunostimulatory effect of sCD40L, CpG-DNA and SLE serum. These cells produced low level of IL-12 but high level of IL-10. They had attenuated allostimulatory effect on T cell activation and proliferation comparable to normal aaDCs and demonstrated differential immunomodulatory effects on naïve and memory T cells. These aaDCs were capable of inducing IL-10 producing regulatory T effectors from naïve T cells whereas they modulated cytokine profile with suppressed production of IFN-γ and IL-17 by co-cultured memory T cells with attenuated proliferation. The tolerogenicity of aaDCs was shown to be superior than those generated using vitD3 alone in lupus patients. aaDCs expressed lower level of RelB but apoptosis of DCs and IL12/IL-10 imbalance were not found to account for their tolerogenicity. Conclusions: Combination of vitD3 and dexamethasone represented a feasible method in the generation of tolerogenic DCs from SLE patients.-
dc.languageeng-
dc.publisherPacini Editore SpA. The Journal's web site is located at http://www.clinexprheumatol.org-
dc.relation.ispartofClinical and Experimental Rheumatology-
dc.subjectLupus-
dc.subjectDendritic cells-
dc.titleAlternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function-
dc.typeConference_Paper-
dc.identifier.emailLo, Y: yloa@hkucc.hku.hk-
dc.identifier.emailMok, TMY: temy@hkucc.hku.hk-
dc.identifier.authorityMok, TMY=rp00490-
dc.identifier.hkuros253068-
dc.identifier.volume33-
dc.identifier.issue3, Suppl 90-
dc.identifier.spageS-21-
dc.identifier.epageS-21-
dc.publisher.placeItaly-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats